Send us Fan Mail

New RAS drug cuts death risk 60% and WILL change cancer treatment forever. #Chemotherapy #TargetedTherapy #Daraxonrasib

--------------------------------------------
Description:
Something new and absolutely amazing just came out in new cancer drug research…

and it’s not getting nearly the attention it should.
This isn’t another “maybe someday” idea—
it’s real Phase 3 clinical trial data and an approval right around the corner.

And it targets one of the hardest problems in cancer:
KRAS, and the entire RAS pathway in general. That covers more than 25% of ALL cancers. Including brain metastases. And it provides a new and relatively easy way to target things that have been very difficult in th epast.

In this breakdown, Dr. Chaplin explains:
• why KRAS has been nearly impossible to treat
• what makes this new approach completely different
• and why this will impact multiple cancers—not just one
• when this drug should be available and what to do in the meantime

If you or someone you care about is dealing with cancer,
this is worth understanding.

--------------------------------------------

Citations:

Press release April 13 https://ir.revmed.com/news-releases/news-release-details/daraxonrasib-demonstrates-unprecedented-overall-survival-benefit/
2025 MotY https://drughunter.com/articles/daraxonrasib-rmc-6236-the-2025-molecule-of-the-year
RASolute 302 Clinical Trial https://clinicaltrials.gov/study/NCT06625320
More clinical trials https://www.cancer.gov/research/participate/clinical-trials/intervention/daraxonrasib

--------------------------------------------

Inquiries:

info@elevatingcancertreatment.com

https://elevatingcancertreatment.com

--------------------------------------------

Disclaimer:
The information provided in this podcast is for educational and informational purposes only, and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard or read in this podcast or on this channel.
Reliance on any information provided by Dr. Jay Chaplin or Elevating Cancer Treatment is solely at your own risk. Dr. Jay Chaplin is a scientist and drug developer, not a medical doctor providing patient care. The content presented here reflects general scientific understanding and research, and may not be applicable to your individual health circumstances. Individual medical conditions and treatments vary, and no two situations are exactly alike.
Always consult with your personal healthcare provider before making any decisions about your health or treatment plan.